Molecular Mechanism of the Selectivity of the Antipsychotic Xanomeline at Muscarinic Receptors

被引：0
|
作者：
Felder, Christian [1 ]
Powers, Alexander [1 ]
Vi Pham [1 ]
Laloudakis, Yiani [1 ]
Christopoulos, Arthur [1 ]
Paul, Steven [1 ]
Valant, Celine [1 ]
Dror, Ron [1 ]
机构：
[1] Karuna Therapeut, Indianapolis, IN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2020年 / 45卷 / SUPPL 1期
关键词：
Acetylcholine Esterase Inhibitors; Muscarinic Receptors; Dementia; Xanomeline; Schizophrenia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T150
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [1] Exploring the Molecular Determinants for Functional Selectivity of the Antipsychotic Xanomeline at Muscarinic Acetylcholine Receptors
    Powers, Alexander S.
    Pham, Vi
    Valant, Celine
    Thal, David
    Christopoulos, Arthur
    Paul, Steven M.
    Felder, Christian C.
    Dror, Ron O.
    [J]. BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S331 - S331
  • [2] XANOMELINE - A NOVEL MUSCARINIC RECEPTOR AGONIST WITH FUNCTIONAL SELECTIVITY FOR M(1) RECEPTORS
    SHANNON, HE
    BYMASTER, FP
    CALLIGARO, DO
    GREENWOOD, B
    MITCH, CH
    SAWYER, BD
    WARD, JS
    WONG, DT
    OLESEN, PH
    SHEARDOWN, MJ
    SWEDBERG, MDB
    SUZDAK, PD
    SAUERBERG, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (01): : 271 - 281
  • [3] Xanomeline binding to and activation of muscarinic receptors.
    Jakubik, J.
    Machova, E.
    El-Fakahany, E. E.
    Dolezal, V
    [J]. NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2009, 2009, : 145 - 148
  • [4] Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists
    Mirza, NR
    Peters, D
    Sparks, RG
    [J]. CNS DRUG REVIEWS, 2003, 9 (02): : 159 - 186
  • [5] Xanomeline's activity in rodent models of psychosis: Role of central muscarinic receptors and augmentation by antipsychotic drugs
    McKinzie, D.
    Fischer, K.
    Meyer, T.
    Yohn, S.
    Popiolek, M.
    Felder, C.
    Paul, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S611 - S612
  • [6] Xanomeline Augments the Therapeutic Actions of Antipsychotic Medications in Animal Models of Psychosis via Agonism of Central Muscarinic Receptors
    Felder, Christian
    McKinzie, David
    Fischer, Kathryn
    Meyer, Timothy
    Yohn, Samantha
    Popiolek, Michael
    Paul, Stephen
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 346 - 346
  • [7] The muscarinic agonist xanomeline has antipsychotic-like activity in animals and in man
    Perry, KW
    Bymaster, FP
    Shannon, HE
    Rasmussen, K
    DeLapp, NW
    Zhang, W
    Ward, JS
    Calligaro, DO
    Fink-Jensen, A
    Sheardown, M
    Jeppesen, L
    Sauerberg, P
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 117 - 118
  • [8] Molecular Mechanisms of Methoctramine Binding and Selectivity at Muscarinic Acetylcholine Receptors
    Jakubik, Jan
    Zimcik, Pavel
    Randakova, Alena
    Fuksova, Kvetoslava
    El-Fakahany, Esam E.
    Dolezal, Vladimir
    [J]. MOLECULAR PHARMACOLOGY, 2014, 86 (02) : 180 - 192
  • [9] SELECTIVITY OF BETHANECHOL ON MUSCARINIC RECEPTORS
    BURLEIGH, DE
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (06) : 398 - 399
  • [10] Receptor - membrane interactions as a potential basis of functional selectivity of xanomeline for M1 and M4 muscarinic receptors
    Randakova, Alena
    Zimcik, Pavel
    Dolejsi, Eva
    Dolezal, Vladimir
    Jakubik, Jan
    [J]. JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 200 - 200
12345